We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

193 hedge funds and large institutions have $90.9M invested in Editas Medicine in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $596K

78% more capital invested

Capital invested by funds: $51M → $90.9M (+$39.9M)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

1% less funds holding

Funds holding: 194 → 193 (-1)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

3.69% less ownership

Funds ownership: 53.03% → 49.34% (-3.7%)

Holders
193
Holders Change
-1
Holders Change %
-0.52%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
52
Closed
26
Calls
$1.83M
Puts
$596K
Net Calls
+$1.24M
Net Calls Change
+$907K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.6M
2
WP
Woodline Partners
California
+$1.38M
3
N
Nuveen
North Carolina
+$1.04M
4
Citadel Advisors
Citadel Advisors
Florida
+$854K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$587K

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$3.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.03M
3
UBS Group
UBS Group
Switzerland
-$959K
4
Bank of America
Bank of America
North Carolina
-$717K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allspring Global Investments
101
Allspring Global Investments
North Carolina
$27.1K -$38.8K -23,735 -66%
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
$26K +$19.3K +11,802 New
TSS
103
Two Sigma Securities
New York
$25.1K +$18.7K +11,402 New
CWM
104
CIBC World Markets
New York
$22.9K -$13.1K -7,991 -43%
GWM
105
Gibbs Wealth Management
Georgia
$22.7K -$49 -30 -0.3%
KCP
106
Kera Capital Partners
California
$22.2K -$905 -553 -5%
KOC
107
Koss-Olinger Consulting
Florida
$22K – – –
RBI
108
Raiffeisen Bank International
Austria
$22K – – –
AIP
109
Ameritas Investment Partners
Nebraska
$18.1K – – –
Legal & General Group
110
Legal & General Group
United Kingdom
$17.1K -$12.2K -7,462 -49%
CIBC Private Wealth Group
111
CIBC Private Wealth Group
Georgia
$16.1K – – –
HT
112
Headlands Technologies
Illinois
$15.8K +$11.8K +7,184 New
FDCDDQ
113
Federation des caisses Desjardins du Quebec
Quebec, Canada
$12.1K – – –
IA
114
IFP Advisors
Florida
$11.1K +$59 +36 +0.7%
Russell Investments Group
115
Russell Investments Group
United Kingdom
$9.96K -$9.46K -5,779 -56%
New York State Common Retirement Fund
116
New York State Common Retirement Fund
New York
$9.67K – – –
AWM
117
Activest Wealth Management
Florida
$8.8K – – –
SS
118
SBI Securities
Japan
$7.59K +$795 +486 +16%
Mirae Asset Global Investments
119
Mirae Asset Global Investments
South Korea
$7.12K +$838 +512 +19%
US Bancorp
120
US Bancorp
Minnesota
$6.56K – – –
National Bank of Canada
121
National Bank of Canada
Quebec, Canada
$6.53K – – –
AB
122
Amalgamated Bank
New York
$6K – – –
SCM
123
Sterling Capital Management
North Carolina
$5.15K +$1.39K +852 +57%
AF
124
Allworth Financial
California
$5.11K +$3.19K +1,947 +518%
GFM
125
GF Fund Management
China
$4.65K – – –
3 4
5
6 7

EDIT Hedge Fund Activity: Q2 2025 in Review

193 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2025, worth a combined $90.9M — up 78% from $51M a quarter earlier.

Fund positioning in EDIT was balanced in Q2 2025: 26 funds opened new positions, 26 closed out, 48 added to existing stakes and 52 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.6M. The largest seller was UBS AM, exiting entirely with an estimated $3.02M sold.

  • 193 institutional investors held Editas Medicine (EDIT) as of Q2 2025, down from 194 in Q1 2025.
  • Funds reported $90.9M of Editas Medicine stock for Q2 2025, up 78% quarter-over-quarter.
  • 26 funds opened new Editas Medicine positions in Q2 2025 and 26 closed out, a net change of 0 holders.
  • The largest Editas Medicine buyer in Q2 2025 was Millennium Management, an estimated $2.6M added.
  • The largest Editas Medicine seller in Q2 2025 was UBS AM, an estimated $3.02M sold.

Based on aggregated 13F filings for Q2 2025.